Skip to main content

European Epigenetics Network Seeks New PIs

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – The EpiGeneSys Network of Excellence, which is funded by the EU's 7th Framework Program and focused on advancing epigenetics and systems biology research, is seeking to bring in nine new investigators by offering three-year research grants of €150,000 ($210,000) for each researcher.

The network, which includes 22 scientific teams in the UK and around Europe, will fund young principal investigators within their first three years of independence who will study biological, computational, or engineering science to develop data relevant to the analysis and modeling of epigenetic mechanisms.

Researchers seeking funding are encouraged to focus their studies on acquisition, storage, modeling, and integration of epigenetics data, and on novel visualization and user guide analysis of massive biological datasets. The investigators also should plan to show active involvement in EpiGeneSys activities, at the level of scientific and technological objectives and at the level of dissemination, training, and long-term activities.

Established researchers seeking to contribute to and partake in the EpiGeneSys activities may apply for an associate membership, which will provide open access to meetings, activities, and other benefits.

EpiGeneSys has identified four areas of focus including characterizing the molecular dynamics of epigenetic systems at the single molecule and cell level; linking genotypes to epigenotypes; investigating how environmental, developmental, and metabolic signals act upon the genome; and understanding epigenetic inheritance through replication, mitosis, and meiosis.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.